Archived Facts

Posts Tagged ‘biovail’

Biovail second-quarter total revenues increase 23% to $238.8 million
Biovail Corporation today announced financial results for the three-month and six-month periods ended June 30, 2010.

Read more on News-Medical-Net

Related Posts:

Biovail Reports Second-Quarter 2010 Financial Results
TORONTO—-Biovail Corporation today announced financial results for the three-month and six-month periods ended June 30, 2010. To the extent that this news release contains forward-looking statements, investors are cautioned that these are based on the Company’s current views, and actual outcomes are not certain.

Read more on Business Wire via Yahoo! Finance

Related Posts:

Biovail Corp.’s merger with Valeant Pharmaceuticals caps the company’s recovery from falling sales and financial scandals. A timeline of the Canadian drug developer’s internal struggles and legal battles:

View full post on All News, Video and Posts related to SECTOR: Health Care

Incoming search terms:

Related Posts:

Canadian drugmaker Biovail Corp. and Valeant Pharmaceuticals International are forming a new company under the Valeant name.

View full post on All News, Video and Posts related to SECTOR: Health Care

Related Posts:

The Securities and Exchange Commission said Wednesday that a judge has rejected its request for a partial summary judgment in the agency’s securities violations case against three executives of Canadian drugmaker Biovail Corp., moving the lawsuit toward trial.

View full post on All News, Video and Posts related to SECTOR: Health Care

Related Posts:

Canadian drugmaker Biovail Corp. said Thursday it posted a loss in the first quarter because of costs involved with licensing a treatment for schizophrenia symptoms and a drug intended to treat a breathing disorder.

See the article here:
Biovail takes 1Q loss on drug acquisition costs

Related Posts: